Corporate

Materia > News > Corporate

Materia Malta Completes First Commercial Export of Medical Cannabis to Germany

0 Comments
  • Inaugural shipment landed in Germany, pre-orders from pharmacy customers to be fulfilled in the coming days
  • Materia Malta becomes the first company to export medical cannabis from Malta for sale in another country

LONDON, June 13, 2022 – Materia (the “Company”), a leading producer and distributor of medical cannabis in Europe, announces that its wholly-owned subsidiary Materia Malta Operating Ltd. (“Materia Malta”) has completed its first export of commercial medical cannabis from its EU GMP manufacturing site.

Read more

Materia Becomes Distribution Partner of Eurox Pharma for German-Produced Medical Cannabis Extracts

LONDON, August 17th, 2021 — Materia, a leading processor and distributor of medical cannabis and CBD wellness products across Europe, is pleased to announce that its wholly-owned subsidiary Materia Deutschland GmbH (“Materia Deutschland”), has entered into an agreement with German medical cannabis manufacturer Eurox Pharma GmbH (“Eurox Pharma”), becoming one of Eurox Pharma’s selected distribution partners for its medical cannabis extracts.

Read more

Materia and Saxonia Diagnostics Announce Exclusive Partnership for Distribution of Pharmacy Cannabis Testing Products

LONDON, May 5th, 2021 — Materia, a medical cannabis and wellness company focused on the European market, today announced that its wholly-owned subsidiary Materia Deutschland GmbH (“Materia Deutschland”) has entered into a partnership with German diagnostics company Saxonia Diagnostics GmbH (“Saxonia Diagnostics”) for the exclusive distribution of its branded cannabis testing products across Germany.

Read more

Materia Attains EU-GMP Certificate and Manufacturing and Import Licence in Germany

0 Comments

LONDON, Jan 28, 2021 /CNW/ — Materia, a medical cannabis and wellness company focused on the European market, is pleased to announce that its wholly-owned subsidiary Materia Deutschland GmbH (“Materia Deutschland” or the “Company”), has received its European Union Good Manufacturing Practices (“EU-GMP”) certificate as well as its manufacturing and import (“MIA”) licence. Following successful inspections by the local authorities, the Company was adjudged to comply with the high standard of production guidelines required to import, conduct manufacturing activities and batch release medical cannabis products.

Read more

Materia tritt mit der Übernahme eines lizenzierten Importeurs und Distributeur für medizinisches Cannabis in den deutschen Markt ein

Hamburg, 14. Mai 2020 – Materia („Materia“ oder das „Unternehmen“), ein Unternehmen für medizinisches Cannabis und CBD Produkte mit Schwerpunkt auf dem europäischen Markt, gibt bekannt, dass es 100% der Gesellschaftsanteile der Cannaktiv GmbH („Cannaktiv“) erworben hat. Cannaktiv wurde im Juni 2018 in Hamburg gegründet und hält alle erforderlichen Erlaubnisse und Zulassungen für den Import und Vertrieb von medizinischem Cannabis an Großhändler und Apotheken in Deutschland. Diese sind:

Read more